Lupin Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Lupin receives UK marketing authorization for Luforbec?? 100/6 æg pMDI,first branded generic alternative to Fostair?? 100/6 æg pMDI for treatmentof Asthma & COPD.".